Latest News
Search News
Celebrating the BCI’s highlights of 2024
20th December 2024
Join us as we look back at some highlights of Barts Cancer Institute’s news stories this year.
Read more
Shining a Spotlight on AI Research at the Barts Cancer Institute
16th December 2024
We explore Nobel-Prize-winning research and the theory behind AI, and speak with Dr Vivek Singh, Dr Oscar Maiques and Professor Claude Chelala, three researchers using cutting-edge AI in their work at the BCI.
Read more
How non-cancerous cells in pancreatic cancer may weaken the immune system’s response
12th December 2024
New research sheds light on how certain non-cancerous cells in pancreatic cancer can affect the body’s natural immune defences and could have a significant impact on patients’ survival.
Read more
Professor Sarah McClelland awarded £1.5m from CRUK to study cancer’s chromosomal chaos
25th November 2024
Congratulations to Professor Sarah McClelland, who has received a £1,500,000 Programme Foundation Award from Cancer Research UK (CRUK), to support her lab’s work at Barts Cancer Institute (BCI), Queen Mary University of London.
Read more
Cancer-killing virus treatment shows promise in brain tumour trial
8th November 2024
An innovative cancer-killing virus shows promise for tackling glioblastoma, an aggressive type of brain tumour, according to new results from a phase I clinical trial co-led by researchers at Barts Cancer Institute.
Read more
€9.8m ERC Synergy grant awarded to study how human tissues stay healthy as we age
5th November 2024
Researchers at the BCI and the Crick have been awarded a €9.8m ERC Synergy grant for their pioneering 6-year project called MUTAHOME.
Read more